Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06404060 · ClinicalTrials.gov registry record · NA

RECOVER-ENERGIZE Platform Protocol_Appendix A (Exercise Intolerance)

A NA study of Long COVID and Long COVID-19, sponsored by Duke University.

Active
Registry status
NA
Development phase
360
Enrollment target
1
Study location

NCT06404060 is a NA study of Long COVID and Long COVID-19 that is active but no longer recruiting, run by Duke University. The registered enrollment target is 360 participants, below the 2,181-participant average among 50 other Long COVID trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06404060, a NA study of Long COVID and Long COVID-19, is active but no longer recruiting, sponsored by Duke University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
1
Study location

Study Summary

This is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and treatment plans if results achieve key study outcomes. This protocol is a prospective, multi-center, multi-arm, randomized, controlled platform trial evaluating interventions to address and improve exercise intolerance and post-exertional malaise (PEM) as manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). The focus of this protocol is to assess interventions that can improve exercise capacity, daily activities tolerance, and quality of life in patients with PASC.

Conditions Studied

Long COVID Long COVID-19 Long Covid19

Interventions

  • OTHER Education
  • BEHAVIORAL Personalized Cardiopulmonary Rehabilitation

Study Locations (1)

North Carolina

  • All sites listed under NCT06404047 - Durham

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2024-07-17
Est. Completion 2026-05
Phase NA

Sponsor

Duke University

1,725 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06404060

The ClinicalTrials.gov registry entry for NCT06404060 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,181-participant average among 50 other Long COVID trials with a reported enrollment target (83% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Long COVID appearing as the primary indexed condition, and to 2 interventions - of which Education is the first listed.

NCT06404060 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06404060 about?

NCT06404060 is a clinical study titled "RECOVER-ENERGIZE Platform Protocol_Appendix A (Exercise Intolerance)". This is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and treatment plans if results achieve key study outcomes. Thi...

What is the current status of trial NCT06404060?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2024-07-17. Estimated completion is 2026-05.

What conditions does trial NCT06404060 study?

This clinical trial studies the following conditions: Long COVID, Long COVID-19, Long Covid19.

What interventions are being tested in trial NCT06404060?

The interventions under investigation include: Education (OTHER), Personalized Cardiopulmonary Rehabilitation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06404060?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06404060 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Long COVID

All registered trials for this condition

Long COVID-19

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.